MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P.
Dudda JC, et al. Among authors: romero p.
Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006.
Immunity. 2013.
PMID: 23601686
Free PMC article.